What type of study is this?

This is a In Vitro Study study (also classified as: Animal Study).

Neuroprotective effects of Artemisia monosperma against LPS-induced neuroinflammation via TLR4 modulation and myeloperoxidase inhibition: metabolomic and molecular insights

View Full Paper

Ask AI

Bookmark

Authors

Analysis shows neuroprotective potential and modulates TLR4 in Neuro 2a cells, suggesting new therapies for neuroinflammatory disorders.

Artemisia monosperma significantly reduces neuroinflammation and oxidative stress in Neuro 2a cells, improving neuroprotection.
The extract shows antioxidant capacities with total phenolic and flavonoid contents of 73.85 μg GA E/mg and 22.38 µg RE/mg, respectively.
Analysis used LC-ESI-TOF–MS/MS to identify 48 polyphenolic compounds, highlighting the metabolomic profile and effectiveness.
The study reveals potential for Artemisia monosperma in treating neurodegenerative conditions by inhibiting TLR4 and myeloperoxidase.

Donia et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

Analysis shows neuroprotective potential and modulates TLR4 in Neuro 2a cells, suggesting new therapies for neuroinflammatory disorders.

Artemisia monosperma significantly reduces neuroinflammation and oxidative stress in Neuro 2a cells, improving neuroprotection.
The extract shows antioxidant capacities with total phenolic and flavonoid contents of 73.85 μg GA E/mg and 22.38 µg RE/mg, respectively.
Analysis used LC-ESI-TOF–MS/MS to identify 48 polyphenolic compounds, highlighting the metabolomic profile and effectiveness.
The study reveals potential for Artemisia monosperma in treating neurodegenerative conditions by inhibiting TLR4 and myeloperoxidase.

Donia et al. (2025) studied this question.

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark